Cargando…
Truncating mutations in SPAST patients are associated with a high rate of psychiatric comorbidities in hereditary spastic paraplegia
BACKGROUND: The hereditary spastic paraplegias (HSPs) are a rare and heterogeneous group of neurodegenerative disorders that are clinically characterised by progressive lower limb spasticity. They are classified as either ‘pure’ or ‘complex’ where spastic paraplegia is complicated with additional ne...
Autores principales: | Chelban, Viorica, Tucci, Arianna, Lynch, David S, Polke, James M, Santos, Liana, Jonvik, Hallgeir, Groppa, Stanislav, Wood, Nicholas W, Houlden, Henry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Neurology, Neurosurgery, and Psychiatry
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537546/ https://www.ncbi.nlm.nih.gov/pubmed/28572275 http://dx.doi.org/10.1136/jnnp-2017-315796 |
Ejemplares similares
-
Loss of seryl-tRNA synthetase (SARS1) causes complex spastic paraplegia and cellular senescence
por: Verdura, Edgard, et al.
Publicado: (2022) -
Therapeutic Strategies for Mutant SPAST-Based Hereditary Spastic Paraplegia
por: Mohan, Neha, et al.
Publicado: (2021) -
A novel truncating variant of SPAST associated with hereditary spastic paraplegia indicates a haploinsufficiency pathogenic mechanism
por: Nan, Haitian, et al.
Publicado: (2022) -
Truncating mutations of SPAST associated with hereditary spastic paraplegia indicate greater accumulation and toxicity of the M1 isoform of spastin
por: Solowska, Joanna M., et al.
Publicado: (2017) -
Reduced acetylated α-tubulin in SPAST hereditary spastic paraplegia patient PBMCs
por: Wali, Gautam, et al.
Publicado: (2023)